$0.14
$0.00 (0.00%)
End-of-day quote: 05/17/2024
OTCPK:ELTP
Elite Pharmaceuticals Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| PFE | Pfizer | NYSE | Outperform | $28.64 | $32.87 | 0.00% | 6 | $162.29B |
| TEVA | Teva Pharmaceutical Industries | NYSE | Outperform | $16.29 | $11.59 | 0.00% | 9 | $18.45B |
| VTRS | Viatris Inc | NASDAQ | Hold | $10.98 | $11.73 | 0.00% | 5 | $13.32B |
| AUROPHARMA | Aurobindo Pharma | NSEI | Outperform | Rp1.20k | Rp1.09k | 0.00% | 20 | Rp653.50B |
| HIK | Hikma Pharmaceuticals PLC | LSE | Outperform | £19.78 | £28.11 | 0.00% | 9 | £4.42B |
| COLL | Collegium Pharmaceutical | NasdaqGS | Outperform | $32.47 | $37.75 | 0.00% | 1 | $1.24B |
| EGRX | Eagle Pharmaceuticals | NasdaqGM | - | $4.76 | $17.00 | 0.00% | 0 | $61.69M |
| ENDP.Q | Endo International | OTCPK | - | $0.00 | $1.33 | 0.00% | 0 | $1.18M |
